常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-17.55/0.08
|
|
企业价值
23.34M
|
| 资产负债 |
|
每股账面净值
-0.47
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
1.62M
|
|
每股收益
0.44
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2025/11/20 23:17 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment. |

6.05 
